ENSYSCE BIOSCIENCES INC (ENSC)

US2936024056 - Common Stock

8.1  +0.15 (+1.89%)

After market: 7.775 -0.32 (-4.01%)

ENSYSCE BIOSCIENCES INC

NASDAQ:ENSC (12/20/2024, 8:07:14 PM)

After market: 7.775 -0.32 (-4.01%)

8.1

+0.15 (+1.89%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%108.05%
Sales Q2Q%685.29%
CRS71.71
6 Month7.98%
Overview
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Ins Owners1.54%
Inst Owners4.41%
Market Cap8.02M
Shares990.00K
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts82.86
Short Float %N/A
Short Ratio0.05
IPO12-01 2017-12-01
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ENSC Daily chart

Company Profile

Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The company is headquartered in La Jolla, California and currently employs 7 full-time employees. The company went IPO on 2017-12-01. The firm develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. Its pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection (TAAP) platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant (MPAR) platform. The TAAP platform is designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription opioid drug abuse. The MPAR platform, when combined with its TAAP prodrugs, is designed to seek to prevent abuse of prescription drugs but also to reduce overdose occurrences. Additionally, nafamostat di-mesylate (nafamostat), which is an ingredient in its overdose protection combination products, is also being developed for the intended purpose of treating infection and pulmonary lung diseases.

Company Info

ENSYSCE BIOSCIENCES INC

7946 Ivanhoe Avenue, Suite 201

La Jolla CALIFORNIA

P: 18582634196

CEO: Daniel B. Silvers

Employees: 7

Website: https://ensysce.com/

ENSC News

News Image12 days ago - ACCESSWIREEnsysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product
ChartMill News Image16 days ago - ChartmillWhich stocks are moving on Friday?

Here are the top movers in Friday's session, showcasing the stocks with significant price changes.

ChartMill News Image16 days ago - ChartmillLet's take a look at the stocks that are in motion in today's session.

Which stocks are experiencing notable movement on Friday?

ChartMill News Image16 days ago - ChartmillThe market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.

Friday's session: gap up and gap down stocks

News Image18 days ago - ACCESSWIREEnsysce Biosciences Announces Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR
News Image19 days ago - ACCESSWIREEnsysce Biosciences Announces 1-for-15 Reverse Stock Split

ENSC Twits

Here you can normally see the latest stock twits on ENSC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example